SYMPHOGEN A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmarkIFRS
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2020
N/A
2021
N/A
2022
2022/9
2023
2023/9
2024
2024/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 21.8% 0.5% 0.4%  
Credit score (0-100)  0 0 4 99 99  
Credit rating  N/A N/A B AAA AAA  
Credit limit (mDKK)  -17.2 10.8 0.0 25.0 31.6  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (mDKK) 
2020
N/A
2021
N/A
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  113 459 70 471 475  
Gross profit  113 459 70.0 206 221  
EBITDA  -189 94.5 -336 66.5 67.9  
EBIT  -189 94.5 -336 38.7 43.3  
Pre-tax profit (PTP)  -204.7 86.9 165.7 31.8 37.6  
Net earnings  -204.7 86.9 165.7 49.1 37.3  
Pre-tax profit without non-rec. items  -189 94.5 -336 31.8 37.6  

 
See the entire income statement

Balance sheet (mDKK) 
2020
N/A
2021
N/A
2022
2022/9
2023
2023/9
2024
2024/9

Tangible assets total  0.0 0.0 0.0 132 135  
Shareholders equity total  -115 -28.5 137 186 224  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  315 285 303 368 423  

Net Debt  0.0 0.0 0.0 -13.9 -60.1  
 
See the entire balance sheet

Volume 
2020
N/A
2021
N/A
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  113 459 70 471 475  
Net sales growth  -33.1% 307.6% -84.7% 573.3% 0.7%  
Gross profit  113 459 70.0 206 221  
Gross profit growth  -33.1% 307.6% -84.7% 194.1% 7.1%  
Employees  0 0 0 144 154  
Employee growth %  0.0% 0.0% 0.0% 0.0% 6.9%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  315 285 303 368 423  
Balance sheet change%  -22.7% -9.7% 6.4% 21.4% 14.8%  
Added value  -188.8 94.5 -336.4 38.7 67.9  
Added value %  -167.6% 20.6% -480.4% 8.2% 14.3%  
Investments  0 0 0 104 -22  

Net sales trend  -3.0 1.0 -1.0 1.0 2.0  
EBIT trend  -2.0 1.0 -1.0 1.0 2.0  

Profitability 
2020
N/A
2021
N/A
2022
2022/9
2023
2023/9
2024
2024/9
EBITDA %  -167.6% 20.6% -480.4% 14.1% 14.3%  
EBIT %  -167.6% 20.6% -480.4% 8.2% 9.1%  
EBIT to gross profit (%)  -167.6% 20.6% -480.4% 18.8% 19.6%  
Net Earnings %  -181.8% 18.9% 236.7% 10.4% 7.9%  
Profit before depreciation and extraordinary items %  -181.8% 18.9% 236.7% 16.3% 13.0%  
Pre tax profit less extraordinaries %  -167.6% 20.6% -480.4% 6.8% 7.9%  
ROA %  -28.9% 25.4% -109.1% 11.8% 11.2%  
ROI %  -28.9% 25.4% -109.1% 14.0% 15.9%  
ROE %  70.1% -120.8% 304.6% 30.3% 18.2%  

Solidity 
2020
N/A
2021
N/A
2022
2022/9
2023
2023/9
2024
2024/9
Equity ratio %  0.0% 0.0% 100.0% 48.1% 52.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 38.6% 41.9%  
Relative net indebtedness %  0.0% 0.0% 0.0% 35.6% 29.3%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -20.9% -88.4%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
N/A
2021
N/A
2022
2022/9
2023
2023/9
2024
2024/9
Quick Ratio  0.0 0.0 0.0 2.5 2.4  
Current Ratio  0.0 0.0 0.0 2.5 2.4  
Cash and cash equivalent  0.0 0.0 0.0 13.9 60.1  

Capital use efficiency 
2020
N/A
2021
N/A
2022
2022/9
2023
2023/9
2024
2024/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 36.9 73.5  
Current assets / Net sales %  0.0% 0.0% 0.0% 42.4% 53.8%  
Net working capital  0.0 0.0 0.0 118.9 150.0  
Net working capital %  0.0% 0.0% 0.0% 25.2% 31.6%  

Employee efficiency 
2020
N/A
2021
N/A
2022
2022/9
2023
2023/9
2024
2024/9
Net sales / employee  0 0 0 3 3  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0